Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Beyond the Monolayer: Leveraging 3D Culture Systems to Decode Mechanisms of Drug Resistance and Therapeutic Vulnerabilities in Colorectal Cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
Colorectal Cancer Statistics, 2023
2023 · External reference
Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2024 · External reference
Early Stage Colon Cancer: Current Treatment Standards, Evolving Paradigms, and Future Directions
10.4251/wjgo.v12.i8.808 · 2020 · External reference
Colorectal Cancer
10.1016/s0140-6736(24)00360-x · 2024 · External reference
Comprehensive Review of Targeted Therapy for Colorectal Cancer
10.1038/s41392-020-0116-z · 2020 · External reference
Signaling Pathways Involved in Colorectal Cancer: Pathogenesis and Targeted Therapy
10.1038/s41392-024-01953-7 · 2024 · External reference
Molecular and Genetic Targets Within Metastatic Colorectal Cancer and Associated Novel Treatment Advancements
10.3389/fonc.2023.1176950 · 2023 · External reference
Tumour Heterogeneity and Resistance to Cancer Therapies
10.1038/nrclinonc.2017.166 · 2018 · External reference
Tumor Heterogeneity: Preclinical Models, Emerging Technologies, and Future Applications
10.3389/fonc.2023.1164535 · 2023 · External reference
Acquired Resistance in Cancer: Towards Targeted Therapeutic Strategies
10.1038/s41568-025-00824-9 · 2025 · External reference
Unveiling the Mechanisms and Challenges of Cancer Drug Resistance
10.1186/s12964-023-01302-1 · 2024 · External reference
Therapy Resistance: Opportunities Created by Adaptive Responses to Targeted Therapies in Cancer
10.1038/s41568-022-00454-5 · 2022 · External reference
Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
10.3390/ijms26051988 · 2025 · External reference
Drug Resistance in Colorectal Cancer: From Mechanism to Clinic
10.3390/cancers14122928 · 2022 · External reference
Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
10.1200/jco.2009.24.6116 · 2010 · External reference
Resistance to Anti‐EGFR Therapies in Metastatic Colorectal Cancer: Underlying Mechanisms and Reversal Strategies
10.1186/s13046-021-02130-2 · 2021 · External reference
The Met Receptor Tyrosine Kinase: A Key Player in Oncogenesis and Drug Resistance
10.1016/j.pharmthera.2013.12.014 · 2014 · External reference
TGFα and Amphiregulin Paracrine Network Promotes Resistance to EGFR Blockade in Colorectal Cancer Cells
10.1158/1078-0432.ccr-14-0774 · 2014 · External reference
Increased TGF‐Alpha as a Mechanism of Acquired Resistance to the Anti‐EGFR Inhibitor Cetuximab Through EGFR‐MET Interaction and Activation of MET Signaling in Colon Cancer Cells
10.1158/1078-0432.ccr-13-0423 · 2013 · External reference
Inhibition of Autocrine HGF Maturation Overcomes Cetuximab Resistance in Colorectal Cancer
10.1007/s00018-023-05071-5 · 2024 · External reference
lncRNA MIR100HG‐Derived miR‐100 and miR‐125b Mediate Cetuximab Resistance via Wnt/Beta‐Catenin Signaling
10.1038/nm.4424 · 2017 · External reference
Exosomal miR‐21 Promotes Proliferation, Invasion and Therapy Resistance of Colon Adenocarcinoma Cells Through Its Target PDCD4
10.1038/s41598-020-65207-6 · 2020 · External reference
A View on Drug Resistance in Cancer
10.1038/s41586-019-1730-1 · 2019 · External reference
The Multi‐Factorial Nature of Clinical Multidrug Resistance in Cancer
10.1016/j.drup.2019.100645 · 2019 · External reference
Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches
10.3389/fonc.2022.891652 · 2022 · External reference
Multi Drug Resistance in Colorectal Cancer‐Approaches to Overcome, Advancements and Future Success
10.1016/j.adcanc.2024.100114 · 2024 · External reference
Colon Cancer Cells Evade Drug Action by Enhancing Drug Metabolism
10.1038/s41388-025-03472-3 · 2025 · External reference
Microbiome in Drug Resistance to Colon Cancer
10.1016/j.cophys.2021.100472 · 2021 · External reference
Apical‐Basal Polarity and the Control of Epithelial Form and Function
10.1038/s41580-022-00465-y · 2022 · External reference
In Vitro and In Vivo Studies of Cancer Cell Behavior Under Nutrient Deprivation
10.1002/cbin.11368 · 2020 · External reference
Guidelines and Definitions for Research on Epithelial‐Mesenchymal Transition
10.1038/s41580-020-0237-9 · 2020 · External reference
Cell Polarity Changes in Cancer Initiation and Progression
10.1083/jcb.202308069 · 2024 · External reference
The Molecular Mechanisms and Therapeutic Strategies of EMT in Tumor Progression and Metastasis
10.1186/s13045-022-01347-8 · 2022 · External reference
EMT, MET, Plasticity, and Tumor Metastasis
10.1016/j.tcb.2020.07.003 · 2020 · External reference
3D Collagen High‐Throughput Screen Identifies Drugs That Induce Epithelial Polarity and Enhance Chemotherapy Response in Colorectal Cancer
10.1038/s42003-025-08699-0 · 2025 · External reference
EMT‐Mediated Regulation of CXCL1/5 for Resistance to Anti‐EGFR Therapy in Colorectal Cancer
10.1038/s41388-021-01920-4 · 2022 · External reference
Epithelial‐Mesenchymal Transition and Cancer Stem Cell‐Like Phenotype Induced by Twist1 Contribute to Acquired Resistance to Irinotecan in Colon Cancer
10.3892/ijo.2017.4044 · 2017 · External reference
The Extracellular Matrix: Its Composition, Function, Remodeling, and Role in Tumorigenesis
10.3390/biomimetics8020146 · 2023 · External reference
Unveiling the Tumor Microenvironment in Colorectal Cancer Therapeutic Resistance
10.3389/fcell.2025.1753180 · 2025 · External reference
Matrix Stiffness and Colorectal Cancer
10.2147/ott.s231010 · 2020 · External reference
Cancer‐Associated Fibroblasts Require Proline Synthesis by PYCR1 for the Deposition of Pro‐Tumorigenic Extracellular Matrix
10.1038/s42255-022-00582-0 · 2022 · External reference
Patient‐Specific Colorectal‐Cancer‐Associated Fibroblasts Modulate Tumor Microenvironment Mechanics
10.1016/j.isci.2024.110060 · 2024 · External reference
Colon Cancer Stem Cells
10.1007/s00109-009-0518-4 · 2009 · External reference
Cancer Stem Cells From Colorectal Cancer‐Derived Cell Lines
10.1073/pnas.0915135107 · 2010 · External reference
The Role of Colorectal Cancer Stem Cells in Metastatic Disease and Therapeutic Response
10.3390/cancers3010319 · 2011 · External reference
Cancer Stem Cells in Colorectal Cancer and the Association With Chemotherapy Resistance
10.1007/s12032-021-01488-9 · 2021 · External reference
Cancer Stem Cell‐Driven Drug Resistance in Colorectal Carcinoma: Molecular Aspects and Therapeutic Potentials
10.1186/s12943-025-02557-7 · 2026 · External reference
Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem‐Cell‐Like Properties
10.1016/j.cell.2012.12.012 · 2013 · External reference
The Role of Cancer Stem Cells in Colorectal Cancer: From the Basics to Novel Clinical Trials
10.3390/cancers13051092 · 2021 · External reference
Targeting Colorectal Cancer Stem‐Like Cells: Overcoming Therapeutic Resistance and Reprogramming the Immunosuppressive Niche
10.1016/j.canlet.2026.218665 · 2026 · External reference
Cancer Metabolism: A Therapeutic Perspective
10.1038/nrclinonc.2016.60 · 2017 · External reference
Hallmarks of Cancer: New Dimensions
10.1158/2159-8290.cd-21-1059 · 2022 · External reference
Hallmarks of Cancer: The Next Generation
10.1016/j.cell.2011.02.013 · 2011 · External reference
Understanding the Intersections Between Metabolism and Cancer Biology
10.1016/j.cell.2016.12.039 · 2017 · External reference
Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy
10.3390/ijms22126262 · 2021 · External reference
Metabolic Changes Associated With Tumor Metastasis, Part 2: Mitochondria, Lipid and Amino Acid Metabolism
10.1007/s00018-015-2100-2 · 2016 · External reference
Oxidative Phosphorylation as an Emerging Target in Cancer Therapy
10.1158/1078-0432.ccr-17-3070 · 2018 · External reference
MCT1‐Dependent Lactate Recycling Is a Metabolic Vulnerability in Colorectal Cancer Cells Upon Acquired Resistance to Anti‐EGFR Targeted Therapy
10.1016/j.canlet.2024.217091 · 2024 · External reference
ROS/PI3K/Akt and Wnt/Beta‐Catenin Signalings Activate HIF‐1alpha‐Induced Metabolic Reprogramming to Impart 5‐Fluorouracil Resistance in Colorectal Cancer
10.1186/s13046-021-02229-6 · 2022 · External reference
A Brief History of Cell Culture: From Harrison to Organs‐on‐a‐Chip
10.3390/cells13242068 · 2024 · External reference
The Third Dimension Bridges the Gap Between Cell Culture and Live Tissue
10.1038/nrm2236 · 2007 · External reference
Organoids: A Historical Perspective of Thinking in Three Dimensions
10.1083/jcb.201610056 · 2017 · External reference
Organoid Cultures From Normal and Cancer‐Prone Human Breast Tissues Preserve Complex Epithelial Lineages
10.1038/s41467-020-15548-7 · 2020 · External reference
Deconstructing the Third Dimension: How 3D Culture Microenvironments Alter Cellular Cues
2012 · External reference
Is It Time to Start Transitioning From 2D to 3D Cell Culture?
10.3389/fmolb.2020.00033 · 2020 · External reference
Comparison of Cancer Cells in 2D vs 3D Culture Reveals Differences in AKT‐mTOR‐S6K Signaling and Drug Responses
2017 · External reference
Morphological and Functional Analysis of Colorectal Cancer Cell Lines in 2D and 3D Culture Models
10.1038/s41598-025-87660-x · 2025 · External reference
Hypoxia—A Key Regulatory Factor in Tumour Growth
10.1038/nrc704 · 2002 · External reference
Genes and Proteins Expression Profile of 2D vs 3D Cancer Models: A Comparative Analysis for Better Tumor Insights
10.1007/s10616-025-00714-w · 2025 · External reference
Comparative Analysis Between 2D and 3D Colorectal Cancer Culture Models for Insights Into Cellular Morphological and Transcriptomic Variations
10.1038/s41598-023-45144-w · 2023 · External reference
Morphogenesis and Oncogenesis of MCF‐10A Mammary Epithelial Acini Grown in Three‐Dimensional Basement Membrane Cultures
10.1016/s1046-2023(03)00032-x · 2003 · External reference
Three‐Dimensional Culture System Identifies a New Mode of Cetuximab Resistance and Disease‐Relevant Genes in Colorectal Cancer
2017 · External reference
Exploring Experimental Models of Colorectal Cancer: A Critical Appraisal From 2D Cell Systems to Organoids, Humanized Mouse Avatars, Organ‐on‐Chip, CRISPR Engineering, and AI‐Driven Platforms‐Challenges and Opportunities for Translational Precision Oncology
10.3390/cancers17132163 · 2025 · External reference
A Rectal Cancer Organoid Platform to Study Individual Responses to Chemoradiation
10.1038/s41591-019-0584-2 · 2019 · External reference
Medium‐Throughput Drug Screening of Patient‐Derived Organoids From Colorectal Peritoneal Metastases to Direct Personalized Therapy
10.1158/1078-0432.ccr-20-0073 · 2020 · External reference
The Drug‐Induced Phenotypic Landscape of Colorectal Cancer Organoids
10.1038/s41467-022-30722-9 · 2022 · External reference
Extracellular Matrix Structure
10.1016/j.addr.2015.11.001 · 2016 · External reference
Tissue Cells Feel and Respond to the Stiffness of Their Substrate
10.1126/science.1116995 · 2005 · External reference
Impact of Crosslink Heterogeneity on Extracellular Matrix Mechanics and Remodeling
10.1016/j.csbj.2020.11.038 · 2020 · External reference
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
10.1016/j.cell.2009.10.027 · 2009 · External reference
Integrins as Biomechanical Sensors of the Microenvironment
10.1038/s41580-019-0134-2 · 2019 · External reference
Targeting Integrin Pathways: Mechanisms and Advances in Therapy
10.1038/s41392-022-01259-6 · 2023 · External reference
3D Cell Culture Systems: Tumor Application, Advantages, and Disadvantages
10.3390/ijms222212200 · 2021 · External reference
3D Matrices for Anti‐Cancer Drug Testing and Development
10.1080/10463356.2010.11883480 · 2010 · External reference
In Vitro Three‐Dimensional (3D) Cell Culture Tools for Spheroid and Organoid Models
10.1016/j.slasd.2023.03.006 · 2023 · External reference
Nicotine Inhibits MAPK Signaling and Spheroid Invasion in Ovarian Cancer Cells
10.1016/j.yexcr.2020.112167 · 2020 · External reference
Three‐Dimensional Culture Systems in Cancer Research: Focus on Tumor Spheroid Model
10.1016/j.pharmthera.2016.03.013 · 2016 · External reference
Scaffold‐Based 3D Cell Culture Models in Cancer Research
10.1186/s12929-024-00994-y · 2024 · External reference
Impact of the 3D Microenvironment on Phenotype, Gene Expression, and EGFR Inhibition of Colorectal Cancer Cell Lines
10.1371/journal.pone.0059689 · 2013 · External reference
Biomimetic Macroporous Hydrogel Scaffolds in a High‐Throughput Screening Format for Cell‐Based Assays
10.1002/btpr.30 · 2008 · External reference
EGFR S442 Ectodomain Mutation Confers Cetuximab Resistance That Can Be Overcome by ERBB2 Blockade With Trastuzumab‐Deruxtecan
10.1016/j.canlet.2026.218607 · 2026 · External reference
Identification of a Mutation in the Extracellular Domain of the Epidermal Growth Factor Receptor Conferring Cetuximab Resistance in Colorectal Cancer
10.1038/nm.2609 · 2012 · External reference
Genomic Landscape of Cell‐Free DNA in Patients With Colorectal Cancer
10.1158/2159-8290.cd-17-1009 · 2018 · External reference
Functionally‐Relevant Morphological Profiling: A Tool to Assess Cellular Heterogeneity
10.1016/j.tibtech.2017.10.007 · 2018 · External reference
Phenotypic Screening in Cancer Drug Discovery—Past, Present and Future
10.1038/nrd4366 · 2014 · External reference
Cellular Morphological Features Are Predictive Markers of Cancer Cell State
10.1016/j.compbiomed.2020.104044 · 2020 · External reference
Adaptive 3D Self‐Assembly of Colorectal Cancer Cells With Unchanged Tumor Phenotype and Drug Sensitivity
10.1002/cam4.71017 · 2025 · External reference
Dome Formation by a Human Colonic Adenocarcinoma Cell Line (HCA‐7)
1985 · External reference
Broad‐Spectrum Receptor Tyrosine Kinase Inhibitors Overcome De Novo and Acquired Modes of Resistance to EGFR‐Targeted Therapies in Colorectal Cancer
10.18632/oncotarget.26663 · 2019 · External reference
Traject3d Allows Label‐Free Identification of Distinct Co‐Occurring Phenotypes Within 3D Culture by Live Imaging
10.1038/s41467-022-32958-x · 2022 · External reference
Impact of High‐Throughput Screening in Biomedical Research
10.1038/nrd3368 · 2011 · External reference
High‐Throughput Screening: Today's Biochemical and Cell‐Based Approaches
10.1016/j.drudis.2020.07.024 · 2020 · External reference
High Drug Attrition Rates—Where Are We Going Wrong?
10.1038/nrclinonc.2011.34 · 2011 · External reference
Three‐Dimensional Cell Culture: The Missing Link in Drug Discovery
10.1016/j.drudis.2012.10.003 · 2013 · External reference
Anticancer Drug Development: The Grand Challenges
10.1038/nrd3144 · 2010 · External reference
Three‐Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell‐Based Biosensors
10.1089/adt.2014.573 · 2014 · External reference
The Use of 3‐D Cultures for High‐Throughput Screening: The Multicellular Spheroid Model
10.1177/1087057104265040 · 2004 · External reference
3D Cell‐Based Assays for Drug Screens: Challenges in Imaging, Image Analysis, and High‐Content Analysis
10.1177/2472555219830087 · 2019 · External reference
3D Cell Cultures Toward Quantitative High‐Throughput Drug Screening
10.1016/j.tips.2022.03.014 · 2022 · External reference
Development of a 3D Tissue Culture‐Based High‐Content Screening Platform That Uses Phenotypic Profiling to Discriminate Selective Inhibitors of Receptor Tyrosine Kinases
10.1177/1087057116657269 · 2016 · External reference
Organoids in High‐Throughput and High‐Content Screenings
10.3389/fceng.2023.1120348 · 2023 · External reference
High‐Throughput Screening in Colorectal Cancer Tissue‐Originated Spheroids
10.1111/cas.13843 · 2019 · External reference
Unresolved reference
External reference
Matrigel: Basement Membrane Matrix With Biological Activity
10.1016/j.semcancer.2005.05.004 · 2005 · External reference
Decellularized Extracellular Matrix as Scaffold for Cancer Organoid Cultures of Colorectal Peritoneal Metastases
10.1093/jmcb/mjac064 · 2023 · External reference
Harnessing Decellularized Extracellular Matrix for Enhanced Fidelity in Colorectal Cancer Organoid and Cell‐Derived Xenograft Models
10.4014/jmb.2405.05036 · 2024 · External reference
Extracellular Matrix Hydrogel Derived From Decellularized Tissues Enables Endodermal Organoid Culture
10.1038/s41467-019-13605-4 · 2019 · External reference
Bone Regeneration Using MMP‐Cleavable Peptides‐Based Hydrogels
10.3390/gels7040199 · 2021 · External reference
Viscoelastic and Phototunable GelMA‐Alginate Hydrogels for 3D Cell Culture
10.1557/s43580-024-00815-2 · 2024 · External reference
Tuning of Mechanical Properties in Photopolymerizable Gelatin‐Based Hydrogels for In Vitro Cell Culture Systems
10.1021/acsapm.2c01980 · 2023 · External reference
Synthesis, Properties, and Biomedical Applications of Gelatin Methacryloyl (GelMA) Hydrogels
10.1016/j.biomaterials.2015.08.045 · 2015 · External reference
Dual Cross‐Linking of Catechol‐Alginate Hydrogels: A Strategy for Enhanced Stability and Sustained Drug Delivery
10.1021/acsomega.5c00077 · 2025 · External reference
The Influence of Crosslinking Agents on the Matrix Properties of Hydrogel Structures Based on Sodium Alginate
10.1134/s2075113324020254 · 2024 · External reference
Hyaluronic Acid‐Based Drug Delivery Systems for Cancer Therapy
10.3390/cells14020061 · 2025 · External reference
Molecular Flexibility of Hyaluronic Acid Has a Profound Effect on Invasion of Cancer Cells
10.1098/rsos.251036 · 2025 · External reference
Patient‐Derived Organoids Can Predict Response to Chemotherapy in Metastatic Colorectal Cancer Patients
10.1126/scitranslmed.aay2574 · 2019 · External reference
High‐Throughput Screening Reveals Higher Synergistic Effect of MEK Inhibitor Combinations in Colon Cancer Spheroids
10.1038/s41598-020-68441-0 · 2020 · External reference
Development of a Miniaturized 3D Organoid Culture Platform for Ultra‐High‐Throughput Screening
10.1093/jmcb/mjaa036 · 2020 · External reference
Assay Establishment and Validation of a High‐Throughput Screening Platform for Three‐Dimensional Patient‐Derived Colon Cancer Organoid Cultures
10.1177/1087057116650965 · 2016 · External reference
Development of an Automated 3D High Content Cell Screening Platform for Organoid Phenotyping
10.1016/j.slasd.2024.100182 · 2024 · External reference
Clustering of Integrin α5 at the Lateral Membrane Restores Epithelial Polarity in Invasive Colorectal Cancer Cells
10.1091/mbc.e16-12-0852 · 2017 · External reference
Cell Surface Integrin α5ß1 Clustering Negatively Regulates Receptor Tyrosine Kinase Signaling in Colorectal Cancer Cells via Glycogen Synthase Kinase 3
10.1093/intbio/zyab009 · 2021 · External reference
Protocol for High‐Throughput Drug Screening in 384‐Well 3D Collagen Cultures of SC Colorectal Cancer Cells Using Colony Morphology as a Readout
10.1016/j.xpro.2025.104300 · 2025 · External reference
Three‐Dimensional Heterotypic Colorectal Cancer Spheroid Models for Evaluation of Drug Response
10.3389/fonc.2023.1148930 · 2023 · External reference
The Blockade of Tumoral IL1beta‐Mediated Signaling in Normal Colonic Fibroblasts Sensitizes Tumor Cells to Chemotherapy and Prevents Inflammatory CAF Activation
10.3390/ijms22094960 · 2021 · External reference
Tumor Organoid‐Immune Co‐Culture Models: Exploring a New Perspective of Tumor Immunity
10.1038/s41420-025-02407-x · 2025 · External reference
Model Systems to Study Tumor‐Microbiome Interactions in Early‐Onset Colorectal Cancer
10.1038/s44321-025-00198-3 · 2025 · External reference
Intratumoral Metabolic Heterogeneity of Colorectal Cancer
10.1152/ajpcell.00139.2021 · 2023 · External reference
Technologies to Assess Drug Response and Heterogeneity in Patient‐Derived Cancer Organoids
10.1146/annurev-bioeng-110220-123503 · 2022 · External reference
Protocol for Seahorse 3D Mito Stress Assay in Patient‐Derived Atypical Teratoid Rhabdoid Tumor CHLA‐05‐ATRT Single Neurospheres
10.1016/j.xpro.2026.104515 · 2026 · External reference
Metabolic Drug Response Phenotyping in Colorectal Cancer Organoids by LC‐QTOF‐MS
10.3390/metabo10120494 · 2020 · External reference
Metabolic Flux Analysis of 3D Spheroids Reveals Significant Differences in Glucose Metabolism From Matched 2D Cultures of Colorectal Cancer and Pancreatic Ductal Adenocarcinoma Cell Lines
10.1186/s40170-022-00285-w · 2022 · External reference
2D Versus 3D Tumor‐on‐Chip Models to Study the Impact of Tumor Organization on Metabolic Patterns In Vitro
10.1038/s41598-025-03504-8 · 2025 · External reference
Metabolomics of 3D Cell Co‐Culture Reveals Alterations in Energy Metabolism at the Cross‐Talk of Colorectal Cancer‐Adipocytes
10.3389/fmed.2024.1436866 · 2024 · External reference
